161 related articles for article (PubMed ID: 17478034)
1. Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study.
Morano S; Mandosi E; Fallarino M; Gatti A; Tiberti C; Sensi M; Gandini L; Buchetti B; Lenti L; Jannini EA; Lenzi A
Eur Urol; 2007 Dec; 52(6):1768-74. PubMed ID: 17478034
[TBL] [Abstract][Full Text] [Related]
2. Editorial comment on: Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study.
Salonia A
Eur Urol; 2007 Dec; 52(6):1775-6. PubMed ID: 17478035
[No Abstract] [Full Text] [Related]
3. Editorial comment on: Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study.
Pickard R
Eur Urol; 2007 Dec; 52(6):1774-5. PubMed ID: 17478036
[No Abstract] [Full Text] [Related]
4. Preliminary observations on the use of propionyl-L-carnitine in combination with sildenafil in patients with erectile dysfunction and diabetes.
Gentile V; Vicini P; Prigiotti G; Koverech A; Di Silverio F
Curr Med Res Opin; 2004 Sep; 20(9):1377-84. PubMed ID: 15383186
[TBL] [Abstract][Full Text] [Related]
5. Daily use of sildenafil improves endothelial function in men with type 2 diabetes.
Deyoung L; Chung E; Kovac JR; Romano W; Brock GB
J Androl; 2012; 33(2):176-80. PubMed ID: 21680809
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus.
Boulton AJ; Selam JL; Sweeney M; Ziegler D
Diabetologia; 2001 Oct; 44(10):1296-301. PubMed ID: 11692178
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease.
Conti CR; Pepine CJ; Sweeney M
Am J Cardiol; 1999 Mar; 83(5A):29C-34C. PubMed ID: 10078540
[TBL] [Abstract][Full Text] [Related]
8. Comparing vardenafil and sildenafil in the treatment of men with erectile dysfunction and risk factors for cardiovascular disease: a randomized, double-blind, pooled crossover study.
Rubio-Aurioles E; Porst H; Eardley I; Goldstein I
J Sex Med; 2006 Nov; 3(6):1037-1049. PubMed ID: 17100937
[TBL] [Abstract][Full Text] [Related]
9. Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 diabetic men with erectile dysfunction.
Burnett AL; Strong TD; Trock BJ; Jin L; Bivalacqua TJ; Musicki B
J Urol; 2009 Jan; 181(1):245-51. PubMed ID: 19013603
[TBL] [Abstract][Full Text] [Related]
10. Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy.
Cavallini G; Modenini F; Vitali G; Koverech A
Urology; 2005 Nov; 66(5):1080-5. PubMed ID: 16286128
[TBL] [Abstract][Full Text] [Related]
11. A dose-escalation study to assess the efficacy and safety of sildenafil citrate in men with erectile dysfunction.
Meuleman E; Cuzin B; Opsomer RJ; Hartmann U; Bailey MJ; Maytom MC; Smith MD; Osterloh IH
BJU Int; 2001 Jan; 87(1):75-81. PubMed ID: 11121996
[TBL] [Abstract][Full Text] [Related]
12. Chronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetes.
Aversa A; Vitale C; Volterrani M; Fabbri A; Spera G; Fini M; Rosano GM
Diabet Med; 2008 Jan; 25(1):37-44. PubMed ID: 18199130
[TBL] [Abstract][Full Text] [Related]
13. Endothelial antioxidant administration ameliorates the erectile response to PDE5 regardless of the extension of the atherosclerotic process.
Vicari E; La Vignera S; Condorelli R; Calogero AE
J Sex Med; 2010 Mar; 7(3):1247-53. PubMed ID: 19674252
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy and safety of sildenafil in men with type 2 diabetes mellitus and erectile dysfunction].
Escobar-Jiménez F;
Med Clin (Barc); 2002 Jun; 119(4):121-4. PubMed ID: 12106522
[TBL] [Abstract][Full Text] [Related]
15. Integrated sildenafil and cognitive-behavior sex therapy for psychogenic erectile dysfunction: a pilot study.
Banner LL; Anderson RU
J Sex Med; 2007 Jul; 4(4 Pt 2):1117-25. PubMed ID: 17627724
[TBL] [Abstract][Full Text] [Related]
16. The impact of daily sildenafil on levels of soluble molecular markers of endothelial function in plasma in patients with erectile dysfunction.
Konstantinopoulos A; Giannitsas K; Athanasopoulos A; Spathas D; Perimenis P
Expert Opin Pharmacother; 2009 Feb; 10(2):155-60. PubMed ID: 19236190
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, tolerability and satisfaction with sildenafil citrate 100-mg titration compared with continued 50-mg dose treatment in men with erectile dysfunction.
Buvat J; Hatzichristou D; Maggi M; Farmer I; Martínez-Jabaloyas JM; Miller PJ; Schnetzler G
BJU Int; 2008 Dec; 102(11):1645-50. PubMed ID: 18710446
[TBL] [Abstract][Full Text] [Related]
18. The South Australian couples sildenafil study: double-blind, parallel-group randomized controlled study to examine the psychological and relationship consequences of sildenafil use in couples.
Hundertmark J; Esterman A; Ben-Tovim D; Austin MA; Dougherty M
J Sex Med; 2007 Jul; 4(4 Pt 2):1126-35. PubMed ID: 17627725
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil citrate and tamsulosin combination is not superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.
Tuncel A; Nalcacioglu V; Ener K; Aslan Y; Aydin O; Atan A
World J Urol; 2010 Feb; 28(1):17-22. PubMed ID: 19855976
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of sildenafil citrate in the treatment of Parkinson-emergent erectile dysfunction: a double-blind, placebo-controlled, randomized study.
Safarinejad MR; Taghva A; Shekarchi B; Safarinejad Sh
Int J Impot Res; 2010; 22(5):325-35. PubMed ID: 20861846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
